Cartalax

Sequence: Ala-Glu-Asp
Maʻemaʻe (HPLC): ≥98.0%
Hoʻokahi haumia: ≤2%
Maʻiʻo peptide: ≥75.0%
ʻO ka hui ʻana o ka ʻakika amino: ≤±15%
Nā Endotoxins Bacterial: ≤50EU/mg

Nā Pōmaikaʻi ʻo Cartalax Peptide
ʻO Cartalax kahi peptide mole liʻiliʻi i haku ʻia me ʻekolu mau amino acids, no ka peptide acidic.

ʻO ka wehewehe e pili ana iā Cartalax
ʻO Cartalax kahi meaʻai meaʻai me kahi peptide cartilage synthesized. Hoʻomaʻamaʻa ia i ka hana o ka cartilage a me nā ʻiʻo iwi ma ka hōʻemi ʻana i kā lākou peptide deficiency a hoʻihoʻi i ka synthesis protein i loko o kā lākou mau cell.
Manaʻo ʻia ʻo Cartalax no nā poʻe a pau i hoʻopilikia ʻia nā ami a me nā iwi, ʻoi aku ka poʻe ʻelemakule a me nā mea pāʻani. He mea kōkua nō hoʻi i ka poʻe me ka osteochondrosis, ka ʻāʻī, ka rumatika osteoporosis, ka gout, nā ʻeha a me nā haʻihaʻi.
ʻO Cartalax kahi peptide bioregulatory pōkole me ka hopena ʻōnaehana ākea ma muli o kona hopena i nā fibroblasts. Ua hōʻike ʻia e pono ai ka ʻili a me nā ʻiʻo pili ʻē aʻe a me nā puʻupaʻa. Hōʻike ka noiʻi e hoʻonui ʻo Cartalax i ka nui o ka nui o ka cell proliferation a hoʻololi i nā pae o nā cytokines like ʻole a me nā molekala hōʻailona e pili ana i ka senescence. ʻO ka holoʻokoʻa, hoʻonui ia i ke olakino a me ka hoʻonui ʻana i ka wā e hoʻemi ana i ka make cell. Manaʻo ʻia ʻo Cartalax he peptide anti-aging, e hoʻihoʻi ana i nā cell kahiko i kahi kūlana ʻōpio a hoʻolōʻihi i ke olakino kino holoʻokoʻa.